It’s a cancer treatment that’s been called a living drug, a game changer, and the most exciting development in cancer treatment in a generation. Penn pioneered it and is working with Children's Hospital of Philadelphia and Novartis to benefit both adult and pediatric patients. Want to know what it’s all about? TIME Magazine takes a deep dive into CAR T therapy, which is now on the cusp of FDA approval. Link
Zarina Ali—the first female neurosurgeon in Pennsylvania Hospital's 266-year history—talks to PhillyVoice about her journey rising through the ranks in a male-dominated profession, being a mother, and serving as a mentor to the next generation of female neurosurgeons. Link
For the fourth year in a row, Penn Medicine hospitals have been ranked among the top 10 hospitals in the nation by U.S. News and World Report, achieving Honor Roll status and top rankings in 11 clinical specialties! Together, the combined enterprise of the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center was ranked as the 10th-best hospital in the United States—and the #1 hospital in Pennsylvania. Thank you to all of the faculty, staff, and families who make it possible. Link
Meet Tugger. He’s a nine-year-old therapy dog who loves munching on bananas, sitting in chairs, and spreading cheer to patients during the holiday season. Our HUPs Pups therapy dogs are the friendliest, furriest members of our care team.
This is a landmark day in the fight against cancer. The U.S. Food and Drug Administration has approved the personalized cellular therapy developed by Penn Medicine, Children's Hospital of Philadelphia, and Novartis to treat acute lymphoblastic leukemia in children and young adults: Link